A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from USC suggests that semaglutide—the drug marketed as Ozempic for diabetes and Wegovy for obesity—may also help reduce alcohol consumption. Published in JAMA Psychiatry, the research found that participants taking the weekly medication experienced lower alcohol cravings, reduced […]
Source link